| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncotelic Therapeutics, Inc. | Chief Business Officer | Common Stock | 16.5M | $428K | $0.03 | 08 Jul 2021 | Direct |
| Oncotelic Therapeutics, Inc. | Chief Business Officer | Stock Options | 675K | 03 Sep 2021 | Direct | ||
| Oncotelic Therapeutics, Inc. | Chief Business Officer | Series A Convertible Preferred Stock | 0 | 31 Mar 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OTLC | Oncotelic Therapeutics, Inc. | 03 Sep 2021 | 1 | $0 | 4 | Chief Business Officer | 08 Sep 2021, 17:00 |
| OTLC | Oncotelic Therapeutics, Inc. | 31 Mar 2021 | 4 | $0 | 4 | CHIEF BUSINESS OFFICER | 16 Jul 2021, 17:35 |